GASTROINTESTINAL CANCER
Clinical trials for GASTROINTESTINAL CANCER explained in plain language.
Never miss a new study
Get alerted when new GASTROINTESTINAL CANCER trials appear
Sign up with your email to follow new studies for GASTROINTESTINAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Short nutrition boost before cancer surgery: does it help?
Disease control TerminatedThis study looked at whether giving well-nourished patients with gastrointestinal cancer a special nutrition drink for just 3 days before surgery could lower complications and shorten hospital stays. The trial was stopped early, so results are limited. It involved 107 adults with…
Matched conditions: GASTROINTESTINAL CANCER
Phase: NA • Sponsor: Société des Produits Nestlé (SPN) • Aim: Disease control
Last updated May 26, 2026 04:16 UTC
-
Engineered immune cells take aim at Hard-to-Treat cancers
Disease control TerminatedThis study tested a new therapy where a person's own white blood cells are collected, genetically modified in a lab to recognize a specific cancer mutation (KRAS G12D), and then given back to attack tumors. It involved 5 adults with advanced gastrointestinal, pancreatic, gastric,…
Matched conditions: GASTROINTESTINAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 04:12 UTC
-
Experimental combo for stomach and bowel cancers shows early promise, but study halted
Disease control TerminatedThis study tested two drugs, ulixertinib and hydroxychloroquine, together in 47 adults with advanced gastrointestinal cancers that have certain gene mutations (MAPK pathway). The goal was to see if the combination could shrink tumors or slow cancer growth. The trial was terminate…
Matched conditions: GASTROINTESTINAL CANCER
Phase: PHASE2 • Sponsor: BioMed Valley Discoveries, Inc • Aim: Disease control
Last updated May 13, 2026 16:02 UTC